Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Germany held the highest Gentamicin Sulfate price among the tracked markets, rising just above 4.5% in Q2 2026 to near USD 176.00/KG from about USD 168.50/KG in Q1, and it was extended Suez route disruption together with steady regional demand that kept the market elevated. The global average climbed from close to USD 157.00/KG to near USD 158.00/KG, a gain of roughly 0.6%, essentially flat as continued gains in the United States and Germany offset a pullback across China and India. Notably, freight and insurance cost pressure tied to shipping disruptions is the common thread lifting the Western markets, and the global average is likely to hold in the USD 155 to 170/KG range through the second half of the year.
The Gentamicin Sulfate is the sulfate salt of gentamicin, a broad-spectrum aminoglycoside antibiotic produced through fermentation using Micromonospora bacterial cultures. It is used across injectable formulations, eye drops, tablets, and topical preparations to treat gram-negative and some gram-positive bacterial infections. Hospital and institutional pharmaceutical procurement takes the largest share of demand, given its established role in acute care antibiotic therapy. Because this product is fermentation-derived and traded internationally as a pharmaceutical active ingredient, fermentation capacity utilization, energy costs affecting production margins, freight and insurance costs, and trade policy including tariffs on raw materials are what really move the price from quarter to quarter.
Freight and insurance cost pressure tied to shipping disruptions along major trade routes shows no clear sign of easing, which points toward continued firmness in the United States and European markets through H2 2026. Asia-Pacific pricing, by contrast, should stay comparatively range-bound as fermentation capacity utilization normalizes.
A further escalation of shipping route disruptions, or additional tariff measures on pharmaceutical raw materials, could be what pushes prices above this forecast. A resolution of the shipping disruptions, or expanded fermentation capacity coming online in India, could be what eases the market back toward the lower end instead.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 155 - 170 | Freight and insurance costs offset by Asia-Pacific softening |
| China | 130 - 145 | Balanced production keeps domestic pricing range-bound |
| India | 148 - 165 | New capacity investment should ease supply constraints |
| United States | 158 - 172 | Tariff costs and hospital stockpiling sustain firmness |
| Germany | 172 - 188 | Shipping disruption and compliance costs maintain the top spot |
The Chinese price eased from about USD 142.00/KG to near USD 137.00/KG, a decline of just above 3.5%. It was moderated export demand from key fermentation-based manufacturing centers, together with balanced production output, that gave the market room to ease.
Why did the price of Gentamicin Sulfate change in Q2 2026 in China?
Manufacturers here maintained controlled output aligned with quality and regulatory standards, and it is this discipline, combined with somewhat softer export orders this quarter, that appears to explain the pullback from the sharper Q1 gain.
The Indian price eased from about USD 160.00/KG to near USD 155.00/KG, a decline of just above 3.1%. It was the same moderated Asia-Pacific export demand affecting the broader region, together with sufficient API availability, that gave the market room to ease.
Why did the price of Gentamicin Sulfate change in Q2 2026 in India?
Balanced production output and sufficient API availability across regional pharmaceutical manufacturing clusters have shaped supply conditions this quarter, and it is this adequacy, combined with somewhat measured procurement from injectable antibiotic producers, that appears to explain the pullback.
The United States price climbed from about USD 156.20/KG to near USD 162.00/KG, a rise of just above 3.7%. It was continued geopolitical volatility elevating freight surcharges and insurance costs, together with resilient hospital procurement demand, that carried the increase.
Why did the price of Gentamicin Sulfate change in Q2 2026 in United States?
Injectable pharmaceutical manufacturers have kept increasing safety stock accumulation in anticipation of further disruption, and it is this stockpiling behavior, combined with tariff-related costs on Chinese and Indian raw materials adding an estimated fifteen to twenty percent to landed prices, that has sustained the upward pressure.
Germany stayed the priciest market by a wide margin, with the price moving from about USD 168.50/KG to near USD 176.00/KG, a gain of just above 4.5%. It was extended shipping transit times through compromised Suez routes, together with steady regional antibiotic demand, that carried the increase.
Why did the price of Gentamicin Sulfate change in Q2 2026 in Germany?
European insurance and freight surcharges have reached unusually high premium levels this year due to the regional shipping disruption, and it is this cost layer, combined with EU regulatory requirements for import documentation and traceability, that has kept German pricing at the top of the range.
The price reached close to USD 142.00/KG in Q1 2026, a rise of just above 4.4% from Q4 2025. It was higher pharmaceutical procurement, together with moderate supply constraints and limited export quotas, that pushed the market higher.
Why did the price of Gentamicin Sulfate change in Q1 2026 in China?
Limited export quotas from key manufacturing hubs, combined with regional logistical factors including port congestion and transport costs, contributed to the upward price adjustment, and buyers responded to the limited availability with timely procurement that reinforced the positive trend.
USD 160.00/KG in Q1 2026 marked a rise of just above 3.2% from Q4 2025. It was steady demand from injectable antibiotic formulators, together with regional supply constraints, that pushed the market higher.
Why did the price of Gentamicin Sulfate change in Q1 2026 in India?
New domestic capacity investment aimed at countering supply risk from other markets has been announced this year, though such projects take time to come online, and in the meantime steady demand against existing supply constraints kept Indian pricing firm through the quarter.
The price reached close to USD 156.20/KG in Q1 2026, a rise of just above 5.4% from Q4 2025. It was geopolitical disruption and elevated shipping surcharges, together with resilient institutional hospital procurement, that pushed the market higher.
Why did the price of Gentamicin Sulfate change in Q1 2026 in United States?
Production facility energy expenses reflected persistently elevated crude oil prices, which compressed fermentation margins, and it was this cost pressure, combined with elevated freight surcharges and insurance costs tied to geopolitical volatility, that drove the sharp United States increase this quarter.
The price reached close to USD 168.50/KG in Q1 2026, a rise of just above 6.6% from Q4 2025. It was extended shipping transit times and North European seaport congestion, together with EU compliance costs, that pushed the market higher.
Why did the price of Gentamicin Sulfate change in Q1 2026 in Germany?
Port congestion at major North European hubs delayed pharmaceutical processing and increased inventory carrying costs, and it was this logistics friction, combined with procedural delays tied to EU import documentation requirements, that drove the sharp German increase this quarter.
This market climbed steadily through 2025 before diverging sharply by region in 2026. Close to USD 140.00/KG in Q1 2025 rose to about USD 144.00/KG, near USD 147.00/KG, and close to USD 149.00/KG by Q4, before continuing to about USD 157.00/KG in Q1 2026 and near USD 158.00/KG in Q2. That is a rise of roughly 12.9% across the window, though the Q2 2026 move was essentially flat as regional trends began pulling in opposite directions.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 158 | +0.6% | ↑ Rising |
| Q1 2026 | 157 | +5.4% | ↑ Rising |
| Q4 2025 | 149 | +1.4% | ↑ Rising |
| Q3 2025 | 147 | +2.1% | ↑ Rising |
| Q2 2025 | 144 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
It was steady pharmaceutical sector procurement, meeting fermentation capacity operating at somewhat reduced utilization across key manufacturing hubs, that drove the consistent 2025 climb. The global average opened near USD 140.00/KG in Q1 and climbed to close to USD 149.00/KG by Q4, a rise of just above 6.4% for the year, with tariff and freight cost pressures beginning to build in the United States and Europe by the closing quarter.
The Chinese price climbed from about USD 130.00/KG in Q1 2025 to near USD 136.00/KG by Q4, a rise of just above 4.6% for the year. It was steady pharmaceutical sector procurement, meeting fermentation capacity running at somewhat reduced utilization rates across key hubs, that kept gradual upward pressure on pricing throughout 2025.
The Indian price climbed from about USD 148.00/KG in Q1 2025 to near USD 155.00/KG by Q4, a rise of just above 4.7% for the year. It was steady demand from injectable antibiotic and generic formulators, meeting supply conditions shaped by fermentation capacity utilization across the region, that kept gradual upward pressure on pricing through 2025.
The United States price climbed from about USD 138.00/KG in Q1 2025 to near USD 148.00/KG by Q4, a rise of just above 7.2% for the year. It was tariff implementation on Chinese and Indian raw materials, adding incremental costs to landed prices, together with resilient antibiotic therapy utilization across acute care networks, that drove the steady climb through 2025.
The German price climbed from about USD 145.00/KG in Q1 2025 to near USD 158.00/KG by Q4, a rise of just above 9.0% for the year, the largest annual gain among the four markets tracked. It was extended Suez route disruption building through the year, together with EU regulatory compliance costs and steady regional antibiotic demand, that kept German pricing on a sustained upward path throughout 2025.
Expert Market Research: Your Source for Real-Time Gentamicin Sulfate Price Intelligence
The Gentamicin Sulfate market depends heavily on fermentation capacity and international shipping conditions, so Expert Market Research tracks both closely across the four markets covered here, alongside trade policy developments including tariffs on pharmaceutical raw materials and hospital procurement demand cycles. This is combined with trade flow data to build the forecasts. For Gentamicin Sulfate pricing data, custom analysis, or procurement strategy support, the team is glad to help.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It is used mainly in injectable formulations, eye drops, tablets, and topical preparations to treat gram-negative and some gram-positive bacterial infections, particularly in hospital and acute care settings.
As of Q2 2026, China averages near USD 137.00/KG, India about USD 155.00/KG, the United States close to USD 162.00/KG, and Germany roughly USD 176.00/KG. Germany's shipping disruption and compliance costs keep it the priciest.
The global average moved from close to USD 149.00/KG in Q4 2025 up to about USD 157.00/KG in Q1 2026, then near USD 158.00/KG in Q2, essentially flat, as continued gains in the United States and Germany offset a pullback in China and India.
The United States and Germany have faced elevated freight surcharges, insurance costs, and tariff-related expenses tied to shipping route disruptions and trade policy. China and India, by contrast, have seen more balanced production and moderated export demand, giving those markets room to ease.
The global average is likely to hold in the USD 155 to 170/KG range, with freight and insurance cost pressure in Western markets offset by comparative softening across the Asia-Pacific region through the back half of the year.
Germany holds the highest cost on shipping disruption and EU compliance costs. The United States sits below that on tariff and stockpiling pressures, India in the middle, and China prices lowest as the domestic production benchmark.
The figures here are updated on a monthly basis, with real-time pricing available directly from the team.
Fermentation capacity utilization sits at the core, since this product is manufactured through a biological process rather than direct chemical synthesis. Freight and insurance costs, trade policy including tariffs, and hospital procurement demand cycles add further influence.
China and India together account for a substantial share of global fermentation-based production, while the United States and Germany represent major consuming markets that depend on imports for a meaningful portion of their supply.
Shipping route conditions and freight cost trends are usually the earliest signal worth tracking for Western markets specifically, since they tend to move well ahead of the landed API price. Watching fermentation capacity utilization announcements in China and India also helps anticipate supply-driven price shifts.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.